D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$596M |
| 2 |
Accenture
ACN
|
+$470M |
| 3 |
Intel
INTC
|
+$412M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
Microsoft
MSFT
|
+$776M |
| 4 |
Netflix
NFLX
|
+$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Sleep Number
SNBR
$236M
| $9.53M | 0.01% |
996,149
-86,475
| -8% | -$828K |
|
827
Itaú Unibanco
ITUB
$76.2B
| $9.53M | 0.01% |
+1,794,690
| New | +$9.53M |
|
|
ANSC
828
Agriculture & Natural Solutions Acquisition Corp
ANSC
$470M
| $9.52M | 0.01% |
929,500
+125,000
| +16% | +$1.28M |
|
829
Vanguard Small-Cap Growth ETF
VBK
$20.7B
| $9.52M | 0.01% |
+38,043
| New | +$9.52M |
|
830
Invesco
IVZ
$10B
| $9.51M | 0.01% |
635,691
-350,288
| -36% | -$5.24M |
|
|
PARA
831
DELISTED
Paramount Global Class B
PARA
| $9.46M | 0.01% |
910,437
-2,996,919
| -77% | -$31.1M |
|
832
Revvity
RVTY
$9.92B
| $9.45M | 0.01% |
90,134
-543,510
| -86% | -$57M |
|
833
Evolus
EOLS
$483M
| $9.45M | 0.01% |
871,098
-106,480
| -11% | -$1.16M |
|
834
Euronet Worldwide
EEFT
$3.61B
| $9.44M | 0.01% |
91,240
+53,473
| +142% | +$5.53M |
|
835
Dynavax Technologies
DVAX
$1.13B
| $9.44M | 0.01% |
840,883
+498,845
| +146% | +$5.6M |
|
836
Mobileye
MBLY
$11.4B
| $9.44M | 0.01% |
336,052
+48,324
| +17% | +$1.36M |
|
837
Ameresco
AMRC
$1.43B
| $9.43M | 0.01% |
327,474
-60,255
| -16% | -$1.74M |
|
838
Pennant Group
PNTG
$882M
| $9.4M | 0.01% |
405,376
-16,454
| -4% | -$382K |
|
839
Albany International
AIN
$1.78B
| $9.38M | 0.01% |
111,076
+48,945
| +79% | +$4.13M |
|
840
Arcutis Biotherapeutics
ARQT
$2.12B
| $9.37M | 0.01% |
1,007,384
+790,518
| +365% | +$7.35M |
|
841
Harmony Biosciences
HRMY
$1.92B
| $9.35M | 0.01% |
310,004
+30,569
| +11% | +$922K |
|
842
Molina Healthcare
MOH
$10.2B
| $9.31M | 0.01% |
31,323
+16,252
| +108% | +$4.83M |
|
843
Usana Health Sciences
USNA
$561M
| $9.29M | 0.01% |
205,455
+32,246
| +19% | +$1.46M |
|
844
PACCAR
PCAR
$53.5B
| $9.28M | 0.01% |
90,144
+6,066
| +7% | +$624K |
|
845
Selective Insurance
SIGI
$4.83B
| $9.27M | 0.01% |
98,754
+16,031
| +19% | +$1.5M |
|
846
Century Communities
CCS
$2.05B
| $9.26M | 0.01% |
113,444
+74,256
| +189% | +$6.06M |
|
847
Hims & Hers Health
HIMS
$11.7B
| $9.24M | 0.01% |
457,540
-504,298
| -52% | -$10.2M |
|
848
AGCO
AGCO
$8.1B
| $9.22M | 0.01% |
94,196
-36,235
| -28% | -$3.55M |
|
849
Murphy USA
MUSA
$7.61B
| $9.21M | 0.01% |
19,609
-44,105
| -69% | -$20.7M |
|
850
Credit Acceptance
CACC
$5.91B
| $9.16M | 0.01% |
17,804
+4,679
| +36% | +$2.41M |
|